These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 11157753)

  • 1. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions.
    Tanoue T; Maeda R; Adachi M; Nishida E
    EMBO J; 2001 Feb; 20(3):466-79. PubMed ID: 11157753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of two distinct regions of p38 MAPK required for substrate binding and phosphorylation.
    Gum RJ; Young PR
    Biochem Biophys Res Commun; 1999 Dec; 266(1):284-9. PubMed ID: 10581204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved docking motif in MAP kinases common to substrates, activators and regulators.
    Tanoue T; Adachi M; Moriguchi T; Nishida E
    Nat Cell Biol; 2000 Feb; 2(2):110-6. PubMed ID: 10655591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creation of a stress-activated p90 ribosomal S6 kinase. The carboxyl-terminal tail of the MAPK-activated protein kinases dictates the signal transduction pathway in which they function.
    Smith JA; Poteet-Smith CE; Lannigan DA; Freed TA; Zoltoski AJ; Sturgill TW
    J Biol Chem; 2000 Oct; 275(41):31588-93. PubMed ID: 10922375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and characterization of a substrate selective p38alpha inhibitor.
    Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
    Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
    Hutter D; Chen P; Barnes J; Liu Y
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking interactions induce exposure of activation loop in the MAP kinase ERK2.
    Zhou T; Sun L; Humphreys J; Goldsmith EJ
    Structure; 2006 Jun; 14(6):1011-9. PubMed ID: 16765894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.
    Szedlacsek SE; Aricescu AR; Fulga TA; Renault L; Scheidig AJ
    J Mol Biol; 2001 Aug; 311(3):557-68. PubMed ID: 11493009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.
    Roux PP; Blenis J
    Microbiol Mol Biol Rev; 2004 Jun; 68(2):320-44. PubMed ID: 15187187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo.
    Dimitri CA; Dowdle W; MacKeigan JP; Blenis J; Murphy LO
    Curr Biol; 2005 Jul; 15(14):1319-24. PubMed ID: 16051177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two clusters of residues at the docking groove of mitogen-activated protein kinases differentially mediate their functional interaction with the tyrosine phosphatases PTP-SL and STEP.
    Tárrega C; Blanco-Aparicio C; Muñoz JJ; Pulido R
    J Biol Chem; 2002 Jan; 277(4):2629-36. PubMed ID: 11711538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modular structure of a docking surface on MAPK phosphatases.
    Tanoue T; Yamamoto T; Nishida E
    J Biol Chem; 2002 Jun; 277(25):22942-9. PubMed ID: 11953434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif.
    Barsyte-Lovejoy D; Galanis A; Clancy A; Sharrocks AD
    Biochem J; 2004 Aug; 381(Pt 3):693-9. PubMed ID: 15132737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated 3p kinase is active in the nucleus.
    Zakowski V; Keramas G; Kilian K; Rapp UR; Ludwig S
    Exp Cell Res; 2004 Sep; 299(1):101-9. PubMed ID: 15302577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway.
    Mérienne K; Jacquot S; Zeniou M; Pannetier S; Sassone-Corsi P; Hanauer A
    Oncogene; 2000 Aug; 19(37):4221-9. PubMed ID: 10980595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalysis and function of the p38 alpha.MK2a signaling complex.
    Lukas SM; Kroe RR; Wildeson J; Peet GW; Frego L; Davidson W; Ingraham RH; Pargellis CA; Labadia ME; Werneburg BG
    Biochemistry; 2004 Aug; 43(31):9950-60. PubMed ID: 15287722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of docking motifs in MAP-kinases and nuclear receptors.
    Burgermeister E; Lanzendoerfer M; Scheuer W
    J Biomol Struct Dyn; 2003 Apr; 20(5):623-34. PubMed ID: 12643765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
    Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.
    Pettiford SM; Herbst R
    Oncogene; 2000 Feb; 19(7):858-69. PubMed ID: 10702794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.